Paul Crawford

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Paul Crawford sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).

6 total trials 1 currently recruiting 2 completed upper quartile by trial count

Paul Crawford: 6 sponsored US clinical trials, 1 recruiting.

Paul Crawford sponsors 6 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 2 completed. The most-studied condition in this pipeline is Acupuncture, with 1 trials.

Upper-quartile sponsor footprint

Paul Crawford sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

What is open in the Paul Crawford pipeline

1 recruiting of 6 indexed (17% open); 2 completed (33%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Acupuncture (1 trial), 4 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Paul Crawford: open-pipeline peers nationwide

Peers matched on 6 registered trials and 17% open enrollment, not the therapeutic-area sidebar.

Paul Crawford sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 468101214 0%20%40%60%80% Total trials Recruiting share Paul Crawford23andMeAardvark TherapeuticsAbbisko Therapeutics CoAbGenomics B.V Taiwan BranchAdageneAgendiaAkamis BioAngiodynamics
Paul Crawford sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Paul Crawford sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 6 trials (± recruiting share)

Sponsors near 17% open enrollment (± trial volume)

What to do with this Paul Crawford page

6 registered trials is a research-attention snapshot, not an endorsement of Paul Crawford or any single study.

  • 1 of Paul Crawford's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Acupuncture is the condition Paul Crawford studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Acupuncture trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Paul Crawford pipeline card: 6 registered trials from official public datasets.Report a data error.